|

Platinum-based doublet chemotherapy Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Regeneron Pharmaceuticals1
  • Beijing Pearl Biotechnology Limited Liability Company1

Indications

  • Cancer2
  • Advanced Solid Tumors1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Other1 trial

A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive
Phase 3

Los Angeles, California1 trial

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

Valkyrie Clinical Trials

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.